Adial Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Deferred Revenue, Current
Adial Pharmaceuticals, Inc. (ADIL) had Disposal Group, Including Discontinued Operation, Deferred Revenue, Current of $193.80 thousand as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Discontinued Operations and Disposal Groups › Disposal Group, Including Discontinued Operation, Liabilities, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent · last filed 2025-03-04
- 2024-12-31: Disposal Group, Including Discontinued Operation, Deferred Revenue, Current $193.80K.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Deferred Revenue, Current $193.80K.
| Period end | Disposal Group, Including Discontinued Operation, Deferred Revenue, Current |
|---|---|
| 2024-12-31 | $193.80K 10-K · filed 2025-03-04 |
| 2023-12-31 | $193.80K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |